ECOLAB INC. ECL

Healthcare SIC 2840 - Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing › Soap and Cleaning Compound Manufacturing derived NYSE

General Development of Business.

Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31. International subsidiaries are included in the consolidated financial statements on the basis of their U.S. GAAP (accounting principles generally accepted in the United States of America) November 30 fiscal year ends to facilitate the timely inclusion of such entities in our consolidated financial reporting.

Narrative Description of Business.

A trusted partner for millions of customers, we are a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, we have advanced innovation by integrating science-based solutions, data-driven insights, AI-technology and world-class service. This unique combination enables us to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, we have $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. We help protect one-third of the world's food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Our comprehensive approach protects what's vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.

Last close 288.53 2026-10-23
Market cap $80.88B 2026-06-30 share count
52-week range 243.15 - 309.27

Valuation FY2025 figures against the last close

P/S5.0x
P/E39.6x
P/FCF42.5x
EV/EBITDA23.8x
Dividend yield0.9%
Diluted EPS7.28

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $16.08B$15.74B$15.32B$14.19B$12.73B$11.79B$12.56B$12.22B$11.53B$13.15B
Cost of revenue $8.93B$8.90B$9.15B$8.83B$7.62B$6.91B$7.05B$6.88B$6.41B$7.53B
Gross profit $7.15B$6.84B$6.17B$5.36B$5.12B$4.88B$5.52B$5.35B$5.12B$5.62B
R&D $202.0M$207.0M$192.0M$190.0M$186.0M$185.0M$190.0M$193.0M$177.0M$189.0M
SG&A $4.26B$4.23B$4.06B$3.65B$3.42B$3.31B$3.55B$3.51B$3.36B$3.71B
Operating income $2.74B$2.80B$1.99B$1.56B$1.60B$1.40B$1.85B$1.73B$1.75B$1.87B
Interest expense $306.2M$340.3M$348.9M$252.1M$230.6M$304.8M$214.4M$235.5M$272.2M$285.4M
Pre-tax income $2.55B$2.57B$1.76B$1.34B$1.41B$1.16B$1.73B$1.59B$1.56B$1.65B
Income tax $454.6M$439.3M$362.5M$234.5M$270.2M$176.6M$288.6M$321.2M$189.8M$402.9M
Net income $2.08B$2.11B$1.37B$1.09B$1.13B-$1.19B$1.58B$1.44B$1.52B$1.25B
EPS, basic 7.337.434.823.833.95-4.205.414.955.204.20
EPS, diluted 7.287.374.793.813.91-4.155.334.885.124.14
Shares, diluted (wtd. avg.) 285.2M286.6M286.5M286.6M289.1M290.3M292.5M292.8M294.0M296.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $646.2M$1.26B$919.5M$598.6M$359.9M$1.26B$118.8M$243.2M$163.3M$380.4M
Receivables $3.25B$2.87B$2.83B$2.70B$2.48B$2.27B$2.38B$2.66B$2.57B$2.34B
Inventory $1.49B$1.46B$1.50B$1.79B$1.49B$1.29B$1.08B$1.55B$1.45B$1.32B
Total current assets $5.96B$6.03B$5.64B$5.49B$4.69B$5.12B$4.83B$4.68B$4.59B$4.28B
Property, plant and equipment $4.28B$3.75B$3.47B$3.29B$3.29B$3.12B$3.23B$3.84B$3.71B$3.37B
Goodwill $9.23B$7.91B$8.15B$8.01B$8.06B$6.01B$5.57B$5.39B$7.17B$6.38B
Other intangibles $3.69B$3.31B$3.49B$3.68B$4.22B$2.98B$2.93B$3.80B$4.02B$3.82B
Total assets $24.70B$22.39B$21.85B$21.46B$21.21B$18.13B$20.87B$20.07B$19.96B$18.33B
Accounts payable $2.07B$1.81B$1.57B$1.73B$1.38B$1.16B$1.08B$1.26B$1.18B$983.2M
Short-term debt $870.4M$615.7M$630.4M$505.1M$411.0M$17.3M$380.5M$743.6M$564.4M$541.3M
Total current liabilities $5.53B$4.79B$4.35B$4.21B$3.55B$2.93B$3.63B$3.69B$3.48B$3.02B
Total liabilities $14.89B$13.60B$13.77B$14.21B$13.95B$11.92B$12.14B$12.02B$12.31B$11.36B
Retained earnings $12.83B$11.52B$10.08B$9.32B$8.81B$8.24B$9.99B$8.91B$8.01B$6.97B
Total equity $9.77B$8.76B$8.07B$7.26B$7.25B$6.20B$8.73B$8.05B$7.65B$6.94B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $2.95B$2.81B$2.41B$1.79B$2.06B$1.86B$2.42B$2.28B$2.09B$1.94B
Depreciation and amortisation $672.6M$634.9M$616.7M$618.5M$604.4M$594.3M$569.1M$535.9M$500.1M$561.0M
Stock-based compensation $136.6M$134.8M$95.1M$87.8M$89.5M$82.1M$84.0M$88.0M$85.5M$85.7M
Capital expenditure $1.05B$994.5M$774.8M$712.8M$643.0M$489.0M$731.3M$778.7M$787.4M$756.8M
Investing cash flow -$2.71B-$433.8M-$990.5M-$716.8M-$4.58B-$414.5M-$1.20B-$1.03B-$1.73B-$773.6M
Financing cash flow -$853.3M-$2.02B-$1.05B-$837.3M$1.60B-$341.8M-$1.35B-$1.17B-$522.7M-$868.2M
Dividends paid $753.6M$664.3M$617.3M$602.8M$566.4M$560.8M$552.9M$494.8M$443.4M$427.5M
Buybacks $783.8M$986.5M$13.7M$518.2M$106.6M$146.2M$353.7M$562.4M$600.3M$739.6M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-018357.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B 20B Revenue, FY2016: 13.2B Gross profit, FY2016: 5.6B Net income, FY2016: 1.2B Revenue, FY2017: 11.5B Gross profit, FY2017: 5.1B Net income, FY2017: 1.5B Revenue, FY2018: 12.2B Gross profit, FY2018: 5.3B Net income, FY2018: 1.4B Revenue, FY2019: 12.6B Gross profit, FY2019: 5.5B Net income, FY2019: 1.6B Revenue, FY2020: 11.8B Gross profit, FY2020: 4.9B Net income, FY2020: -1.2B Revenue, FY2021: 12.7B Gross profit, FY2021: 5.1B Net income, FY2021: 1.1B Revenue, FY2022: 14.2B Gross profit, FY2022: 5.4B Net income, FY2022: 1.1B Revenue, FY2023: 15.3B Gross profit, FY2023: 6.2B Net income, FY2023: 1.4B Revenue, FY2024: 15.7B Gross profit, FY2024: 6.8B Net income, FY2024: 2.1B Revenue, FY2025: 16.1B Gross profit, FY2025: 7.2B Net income, FY2025: 2.1B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $13.15B $11.53B $12.22B $12.56B $11.79B $12.73B $14.19B $15.32B $15.74B $16.08B
Gross profit $5.62B $5.12B $5.35B $5.52B $4.88B $5.12B $5.36B $6.17B $6.84B $7.15B
Net income $1.25B $1.52B $1.44B $1.58B -$1.19B $1.13B $1.09B $1.37B $2.11B $2.08B

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2840

TickerCompanyMarket capP/ERevenue growth
PG PROCTER & GAMBLE Co $374.28B 24.3x 3.3%
CHD CHURCH & DWIGHT CO INC /DE/ $24.95B 34.8x 1.6%
SCL STEPAN CO $1.45B 31.2x 7.0%
UL UNILEVER PLC — — —
WNW Meiwu Technology Co Ltd — — 4,368.0%
BYAH Park Ha Biological Technology Co., Ltd. — — 6.0%